Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development

BACKGROUND: The mRNA-based cancer vaccine has been considered a promising strategy and the next hotspot in cancer immunotherapy. However, its application on cholangiocarcinoma remains largely uncharacterized. This study aimed to identify potential antigens of cholangiocarcinoma for development of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xing, Tang, Tianyu, Zhang, Gang, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938044/
https://www.ncbi.nlm.nih.gov/pubmed/33685460
http://dx.doi.org/10.1186/s12943-021-01342-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938044/
https://www.ncbi.nlm.nih.gov/pubmed/33685460
http://dx.doi.org/10.1186/s12943-021-01342-6

Ejemplares similares